Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verzenio (abemaciclib)
Pharma
Novartis pressures Lilly with Kisqali's broad breast cancer nod
The expanded label separates Novartis' Kisqali from Eli Lilly's Verzenio by covering patients who don't have cancer cells in their lymph nodes.
Angus Liu
Sep 17, 2024 3:04pm
Lilly lifts guidance by $3B after strong GLP-1 performance
Aug 8, 2024 11:18am
ASCO: Lilly seeks prostate cancer redemption after Verzenio flop
May 23, 2024 5:00pm
Lilly’s growth drivers, Verzenio and Jardiance, suffer setbacks
Apr 30, 2024 10:48am
Eli Lilly hit with Verzenio flop in prostate cancer
Feb 7, 2024 10:44am
SABCS: Novartis gives update on Kisqali in early breast cancer
Dec 8, 2023 9:15am
